Showing results (11-20 of 523) with videos related to
Sort By:
Pageof 53
British Journal of Clinical Pharmacology|March 1, 1992
Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in manH Sinzinger, F Rauscha, J O'Grady, et al.American Journal of Hematology|February 1, 1990
Prevalence of a shortened prostacyclin half-life in plasma in healthy adults: results of a screening investigationH Sinzinger, F Rauscha, P Fitscha, et al.Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandinsP Fitscha, J Kaliman, J O'Grady, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1992
The diminished extracellular matrix production induced by isradipine, a calcium channel blocker, is completely abolished by cyclooxygenase inhibitionP Fitscha, A Keiler, F Rauscha, et al.Thrombosis Research|February 1, 1992
Modification of platelet function by isosorbide dinitrate in patients with coronary artery diseaseH Sinzinger, I Virgolini, J O'Grady, et al.Acta Medica Austriaca|January 1, 1982
[Value of the detection of arteriosclerotic lesions with labeled autologous thrombocytes]H Sinzinger, K Silberbauer, P Fitscha, et al.European Journal of Clinical Pharmacology|January 1, 1992
Isradipine improves platelet function in hypertensivesH Sinzinger, I Virgolini, F Rauscha, et al.Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|March 1, 1994
Isradipine inhibits mitotic and proliferative activity in the arterial wallP Fitscha, F Rauscha, J O'Grady, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 1, 1988
Diminished platelet residence time on active human atherosclerotic lesions in-vivo--evidence for an optimal dose of aspirin?H Sinzinger, J Kaliman, P Fitscha, et al.Wiener Klinische Wochenschrift|September 13, 1985
[Accelerated degradation of prostacyclin in diabetic plasma--a further factor in the impairment of hemostatic balance?]H Sinzinger, J Kaliman, P Fitscha, et al.Pageof 53